Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
I have appreciated the support from my manager, leadership and team. The environment at KPTI is fast paced with opportunity to innovate and try new things - with a priority and focus on people and patients first.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Teamwork and support from my KPTI colleagues
Qu’est-ce qui vous rend le plus heureux au travail?
Being a resource and cross functional partner to my KPTI colleagues and leadership.
Quelles sont les meilleures choses à propos de votre équipe?
We are one team. Everyone supports each other regardless of their role or function. This allows us to achieve our goals and objectives.
Other Employee Reviews for Karyopharm Therapeutics
×